Abstract
Resuscitation promoting factors (Rpf) are a family of proteins secreted by actively growing actinobacteria, including Mycobacterium tuberculosis. Experimental evidence suggests that Rpfs play a distinct role in bacterial resuscitation and re-growth as well as reactivation of chronic tuberculosis in mice. The striking similarity of the Rpfs structure to cell wall hydrolysing enzymes has provided a basis for the development of novel low molecular weight inhibitors of Rpfs activity. In particular, recently characterised nitrophenylthiocyanate compounds could be considered as a promising scaffold for generation of therapeutic agents targeting reactivation of latent tuberculosis. This review describes recent progress in understanding of molecular mechanisms of Rpf biological activity.
Keywords: Inhibitors, latency, nitrophenylthiocyanates, resuscitation, Rpf, tuberculosis, Mycobacterium tuberculosis, cell wall hydrolysing enzymes, therapeutic agents, molecular mechanisms
Protein & Peptide Letters
Title:Resuscitation-promoting Factors (Rpf): In Search of Inhibitors
Volume: 19 Issue: 10
Author(s): Arseny S. Kaprelyants, Galina V. Mukamolova, Alessia Ruggiero, Vadim A. Makarov, Galina R. Demina, Margarita O. Shleeva, Vasilii D. Potapov and Pavel A. Shramko
Affiliation:
Keywords: Inhibitors, latency, nitrophenylthiocyanates, resuscitation, Rpf, tuberculosis, Mycobacterium tuberculosis, cell wall hydrolysing enzymes, therapeutic agents, molecular mechanisms
Abstract: Resuscitation promoting factors (Rpf) are a family of proteins secreted by actively growing actinobacteria, including Mycobacterium tuberculosis. Experimental evidence suggests that Rpfs play a distinct role in bacterial resuscitation and re-growth as well as reactivation of chronic tuberculosis in mice. The striking similarity of the Rpfs structure to cell wall hydrolysing enzymes has provided a basis for the development of novel low molecular weight inhibitors of Rpfs activity. In particular, recently characterised nitrophenylthiocyanate compounds could be considered as a promising scaffold for generation of therapeutic agents targeting reactivation of latent tuberculosis. This review describes recent progress in understanding of molecular mechanisms of Rpf biological activity.
Export Options
About this article
Cite this article as:
S. Kaprelyants Arseny, V. Mukamolova Galina, Ruggiero Alessia, A. Makarov Vadim, R. Demina Galina, O. Shleeva Margarita, D. Potapov Vasilii and A. Shramko Pavel, Resuscitation-promoting Factors (Rpf): In Search of Inhibitors, Protein & Peptide Letters 2012; 19 (10) . https://dx.doi.org/10.2174/092986612802762723
DOI https://dx.doi.org/10.2174/092986612802762723 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Genetically Modified Bacteria to Modulate Adaptive Immunity
Current Gene Therapy Stairway to Heaven or Hell? Perspectives and Limitations of Chagas Disease Chemotherapy
Current Topics in Medicinal Chemistry Functional Gene Discovery Using RNA Interference-Based Genomic Screens to Combat Pathogen Infection
Current Drug Discovery Technologies Pharmacogenetics: Relevance to African Healthcare
Current Pharmacogenomics and Personalized Medicine Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Nanoscience & Nanotechnology-Asia Toll-Like Receptors and Inflammation in the CNS
Current Drug Targets - Inflammation & Allergy Antimicrobial Activities of 1-H-Benzimidazole-based Molecules
Current Topics in Medicinal Chemistry Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Redox Proteins as Targets for Drugs Development Against Pathogens
Current Pharmaceutical Design Phenothiazines as Anti-Multi-Drug Resistant Tubercular Agents
Infectious Disorders - Drug Targets Preface [Hot Topic;Marine Natural Products (Guest Editor: Raymond Andersen)]
Current Medicinal Chemistry - Anti-Infective Agents Characterization of pDNA-TMC Nanoparticle Interaction and Stability
Current Drug Delivery Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry Discrimination of Chemical Profiles of Some Bacterial Species by Analyzing Culture Headspace Air Samples Using TD-GC/MS
Current Analytical Chemistry SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update
Anti-Infective Agents Recent Developments in Oral Bait Vaccines for Wildlife
Recent Patents on Drug Delivery & Formulation S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics Development of Neurochemical Normalization (“Agonist Substitution”) Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909
Current Medicinal Chemistry - Central Nervous System Agents Recognition of Protein-coding Genes Based on Z-curve Algorithms
Current Genomics